Difference between revisions of "Part:BBa K3117020"
Lena Schorr (Talk | contribs) |
|||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
<partinfo>BBa_K3117020 short</partinfo> | <partinfo>BBa_K3117020 short</partinfo> | ||
| − | Part BBa_K3117020 is a single chain variable fragment (scFv) of the anti-CD3 antibody. This fragment was used to generate a fusion protein to create a bispecific antibody on the one hand | + | Part BBa_K3117020 is a single chain variable fragment (scFv) of the anti-CD3 antibody. This fragment was used to generate a fusion protein to create a bispecific antibody on the one hand directed against CD3, on the other part against GPA33. |
| − | + | ||
| − | + | ||
| − | + | ||
===Usage and Biology=== | ===Usage and Biology=== | ||
| − | CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell | + | CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell (Chetty et al., 1994). |
| − | + | ||
| − | + | ||
| − | + | ||
| − | + | ||
| + | ===References=== | ||
| − | + | 1. Chetty, R.; Gatter, K. (1994): CD3: structure, function, and role of immunostaining in clinical practice. In: The Journal of pathology 173 (4), S. 303–307. DOI: 10.1002/path.1711730404. | |
| − | + | ||
| − | + | ||
| − | + | ||
Latest revision as of 23:04, 21 October 2019
scFv VH against CD3 codon optimized for CHO expression
Part BBa_K3117020 is a single chain variable fragment (scFv) of the anti-CD3 antibody. This fragment was used to generate a fusion protein to create a bispecific antibody on the one hand directed against CD3, on the other part against GPA33.
Usage and Biology
CD3 is co-expressed with the T cell receptor on T cells. Binding leads to downstream signaling cascades and activation of the T cell (Chetty et al., 1994).
References
1. Chetty, R.; Gatter, K. (1994): CD3: structure, function, and role of immunostaining in clinical practice. In: The Journal of pathology 173 (4), S. 303–307. DOI: 10.1002/path.1711730404.